Outcomes of Surgical Treatment for Graves' Disease: A Single-Center Experience of 216 Cases.

Graves’ disease complication concomitant thyroid cancer intraoperative neural monitoring outcome thyroidectomy

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
07 Feb 2023
Historique:
received: 26 01 2023
accepted: 01 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

The role of surgery in the treatment of Graves' disease (GD) needs to be revisited. The aims of the present retrospective study were to evaluate the outcomes of the current surgical strategy as a definitive treatment of GD at our center and to explore the clinical association between GD and thyroid cancer. A patient cohort of 216 cases from 2013 to 2020 was involved in this retrospective study. The data of the clinical characteristics and follow-up results were collected and analyzed. There were 182 female and 34 male patients. The mean age was 43.9 ± 15.0 years old. The mean duration of GD reached 72.2 ± 92.7 months. Of the 216 cases, 211 had been treated with antithyroid drugs (ATDs) and hyperthyroidism had been completely controlled in 198 cases. A total (75%) or near-total (23.6%) thyroidectomy was performed. Intraoperative neural monitoring (IONM) was applied to 37 patients. The failure of ATD therapy (52.3%) was the most common surgical indication, followed by suspicion of a malignant nodule (45.8%). A total of 24 (11.1%) patients had hoarseness after the operation and 15 (6.9%) patients had transient vocal cord paralysis; 3 (1.4%) had this problem permanently. No bilateral RLN paralysis occurred. A total of 45 patients had hypoparathyroidism and 42 of them recovered within 6 months. Sex showed a correlation with hypoparathyroidism through a univariate analysis. A total of 2 (0.9%) patients underwent a reoperation because of hematomas. A total of 104 (48.1%) cases were diagnosed as thyroid cancer. In most cases (72.1%), the malignant nodules were microcarcinomas. A total of 38 patients had a central compartment node metastasis. A lateral lymph node metastasis occurred in 10 patients. Thyroid carcinomas were incidentally discovered in the specimens of 7 cases. The patients with concomitant thyroid cancer had a significant difference in body mass index, duration of GD, gland size, thyrotropin receptor antibodies and nodule(s) detected. Surgical treatments for GD were effective, with a relatively low incidence of complications at this high-volume center. Concomitant thyroid cancer is one of the most important surgical indications for GD patients. Careful ultrasonic screening is necessary to exclude the presence of malignancies and to determine the therapeutic plan.

Sections du résumé

BACKGROUND BACKGROUND
The role of surgery in the treatment of Graves' disease (GD) needs to be revisited. The aims of the present retrospective study were to evaluate the outcomes of the current surgical strategy as a definitive treatment of GD at our center and to explore the clinical association between GD and thyroid cancer.
METHODS METHODS
A patient cohort of 216 cases from 2013 to 2020 was involved in this retrospective study. The data of the clinical characteristics and follow-up results were collected and analyzed.
RESULTS RESULTS
There were 182 female and 34 male patients. The mean age was 43.9 ± 15.0 years old. The mean duration of GD reached 72.2 ± 92.7 months. Of the 216 cases, 211 had been treated with antithyroid drugs (ATDs) and hyperthyroidism had been completely controlled in 198 cases. A total (75%) or near-total (23.6%) thyroidectomy was performed. Intraoperative neural monitoring (IONM) was applied to 37 patients. The failure of ATD therapy (52.3%) was the most common surgical indication, followed by suspicion of a malignant nodule (45.8%). A total of 24 (11.1%) patients had hoarseness after the operation and 15 (6.9%) patients had transient vocal cord paralysis; 3 (1.4%) had this problem permanently. No bilateral RLN paralysis occurred. A total of 45 patients had hypoparathyroidism and 42 of them recovered within 6 months. Sex showed a correlation with hypoparathyroidism through a univariate analysis. A total of 2 (0.9%) patients underwent a reoperation because of hematomas. A total of 104 (48.1%) cases were diagnosed as thyroid cancer. In most cases (72.1%), the malignant nodules were microcarcinomas. A total of 38 patients had a central compartment node metastasis. A lateral lymph node metastasis occurred in 10 patients. Thyroid carcinomas were incidentally discovered in the specimens of 7 cases. The patients with concomitant thyroid cancer had a significant difference in body mass index, duration of GD, gland size, thyrotropin receptor antibodies and nodule(s) detected.
CONCLUSION CONCLUSIONS
Surgical treatments for GD were effective, with a relatively low incidence of complications at this high-volume center. Concomitant thyroid cancer is one of the most important surgical indications for GD patients. Careful ultrasonic screening is necessary to exclude the presence of malignancies and to determine the therapeutic plan.

Identifiants

pubmed: 36835843
pii: jcm12041308
doi: 10.3390/jcm12041308
pmc: PMC9968166
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur Thyroid J. 2018 Aug;7(4):167-186
pubmed: 30283735
Int J Surg. 2016 Mar;27:118-125
pubmed: 26626367
Br J Surg. 2006 Apr;93(4):434-9
pubmed: 16523447
Endocrine. 2019 Apr;64(1):176-183
pubmed: 30788669
Nat Rev Dis Primers. 2020 Jul 2;6(1):52
pubmed: 32616746
Ann Otol Rhinol Laryngol. 2022 Apr;131(4):341-351
pubmed: 34060342
Thyroid. 2016 Aug;26(8):1144-5
pubmed: 27267495
Endocr Metab Immune Disord Drug Targets. 2021;21(11):2028-2034
pubmed: 33380308
Head Neck. 2019 Feb;41(2):281-285
pubmed: 30537006
Br J Cancer. 2010 Apr 27;102(9):1397-9
pubmed: 20354521
Thyroid. 2021 Feb;31(2):183-192
pubmed: 33023426
Clin Endocrinol (Oxf). 2019 Oct;91(4):571-577
pubmed: 31369161
J Clin Transl Endocrinol. 2019 Feb 07;16:100183
pubmed: 30815364
Thyroid. 2016 Oct;26(10):1343-1421
pubmed: 27521067
J Clin Endocrinol Metab. 2018 Feb 1;103(2):446-451
pubmed: 29211863
Thyroid. 2019 Nov;29(11):1545-1557
pubmed: 31482765
World J Surg. 2023 Feb;47(2):392-401
pubmed: 36182976
J Surg Res. 2020 Jan;245:523-528
pubmed: 31450040
Clin Endocrinol (Oxf). 2016 Jan;84(1):115-20
pubmed: 25581877
World J Surg. 2008 Sep;32(9):1935-9
pubmed: 18392652
Br J Surg. 2014 Mar;101(4):307-20
pubmed: 24402815
Ann Surg. 2021 Jun 1;273(6):1197-1206
pubmed: 33914484
Thyroid. 2005 Oct;15(10):1157-64
pubmed: 16279849
Clin Endocrinol (Oxf). 2013 Nov;79(5):739-46
pubmed: 23521078
Endocrinol Metab (Seoul). 2021 Dec;36(6):1268-1276
pubmed: 34823306
Thyroid. 2017 Jun;27(6):825-831
pubmed: 28457178
Clin Endocrinol (Oxf). 2022 Jun;96(6):747-757
pubmed: 34954838
Br J Surg. 2012 Apr;99(4):515-22
pubmed: 22287122
Ann Surg. 2019 Nov;270(5):755-761
pubmed: 31634179
Laryngoscope. 2011 Jan;121 Suppl 1:S1-16
pubmed: 21181860
Arch Med Sci. 2019 Jan 11;16(2):302-307
pubmed: 32190140
Head Neck. 2020 Aug;42(8):2123-2128
pubmed: 32199035
Thyroid. 2020 Mar;30(3):357-364
pubmed: 31973681
J Endocrinol Invest. 2020 Oct;43(10):1519-1522
pubmed: 32279181
J Otolaryngol Head Neck Surg. 2019 Aug 28;48(1):40
pubmed: 31462328
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Endocrinol Invest. 2020 Jan;43(1):109-116
pubmed: 31327128
Thyroid. 2013 Jul;23(7):879-84
pubmed: 23421548
Thyroid. 2020 Apr;30(4):531-535
pubmed: 31950881
J Clin Med. 2020 Dec 11;9(12):
pubmed: 33322553

Auteurs

Hanxing Sun (H)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Hui Tong (H)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Xiaohui Shen (X)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Haoji Gao (H)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Jie Kuang (J)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Xi Chen (X)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Qinyu Li (Q)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Weihua Qiu (W)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Zhuoran Liu (Z)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Jiqi Yan (J)

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Classifications MeSH